Ars Pharmaceuticals Inc share price logo

Ars Pharmaceuticals Inc Share Price

NASDAQ: SPRY

Small Cap

$9.40

-0.56

(-5.62%)

as on

Ars Pharmaceuticals Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $9.38
    $10.15
    downward going graph

    0.21%

    Downside

    7.98%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $9.79
    $18.9
    downward going graph

    -4.15%

    Downside

    101.06%

    Upside

    downward going graph

Ars Pharmaceuticals Inc share price movements today

Previous Close
$9.96
Open
$9.91
Volume
2.1M
Day's Low - High
$9.38 - $10.15
52 Week Low - High
$9.79 - $18.9

Ars Pharmaceuticals Inc Historical Returns

1 Month Return
-30.97 %
3 Month Return
-33.84 %
1 Year Return
-22.55 %
3 Year Return
0 %
5 Year Return
0 %

Ars Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Ars Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$991.2M

EPS (TTM)

-1.684

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-28.06

Industry PE ratio

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-58.7M

Revenue (TTM)

112.3M

Profit Margin

-42.74%

Return On Equity TTM

3965600.00%

Ars Pharmaceuticals Inc Stock Valuation

Track how Ars Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Ars Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (24.31x)

September 30, 2023

Industry (0.00x)

September 16, 2025

Today (-28.06x)

September 16, 2025

Highest (24.31x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -28.06x

Ars Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ars Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$991.2MNA-28.06-42.74%
BUY$61.1B251.26%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.2B47.46%28.0931.86%
BUY$59.6B0.6%14.131.37%

Stock Returns calculator for Ars Pharmaceuticals Inc Stock including INR - Dollar returns

The Ars Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Ars Pharmaceuticals Inc investment value today

Current value as on today

₹77,454

Returns

₹22,546

(-22.55%)

Returns from Ars Pharmaceuticals Inc Stock

₹27,413 (-27.41%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Ars Pharmaceuticals Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Ars Pharmaceuticals Inc. Average target price of $32.57

Ars Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Ars Pharmaceuticals Inc.

What analysts predicted

71.14%UPSIDE

Target Price

$32.57

Current Price

$9.4

Analyzed by

9 Analysts

Target

$32.57

Ars Pharmaceuticals Inc target price $32.57, a slight upside of 71.14% compared to current price of $9.4. According to 9 analysts rating.

Ars Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Ars Pharmaceuticals Inc Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:58% versus previous 30 day period

Ars Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
-
0
-
0
2
86
7
15
Gross Profit
-6
-7
0
0
0
0
1
85
6
10
Operating Income
-18
-20
-17
-10
-13
-15
-21
47
-37
-47
EBITDA
-18
-20
-17
-10
-13
-15
-21
47
-35
-44
Interest Expense
3
-
-
3
-
-
-
-
-
-
Depreciation
0
0
0
-6
-1
-1
-1
-1
-1
-1
Income Before Tax
-14
-17
-14
-7
-10
-12
-19
50
-33
-44
Income Tax Expense
-3
0
0
3
0
-
-
0
-
-
Net Income
-11
-17
-14
-7
-10
-12
-19
49
-33
-44
Net Profit Margin
-56045.00%
-173700.00%
0.00%
23893.33%
0.00%
-2503.20%
-924.95%
57.67%
-425.69%
-285.57%

Ars Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
17
5
1
0
89
Gross Profit
3
5
0
0
88
Operating Income
0
-19
-35
-67
-3
EBITDA
0
-19
-34
-67
-2
Interest Expense
0
0
0
-
-
Depreciation
0
0
0
0
-7
Income Before Tax
-1
-20
-34
-54
8
Income Tax Expense
0
0
0
0
0
Net Income
-1
-20
-34
-54
7
Net Profit Margin
-5.97%
-367.65%
-2635.41%
-181216.67%
8.97%

Ars Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-17
-14
-7
-10
-12
-19
49
-33
-44
Operating Cash Flow
-16
-12
-17
-6
-7
-14
42
-40
-39
Investing Cash Flow
44
-46
26
-8
-12
16
-101
29
48
Financing Cash Flow
2
0
1
0
0
0
70
0
2
Change in Cash
31
-58
10
-14
-19
3
11
-10
11

Ars Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-23
-1
-20
-34
-54
7
Operating Cash Flow
-18
9
-17
-40
-59
13
Investing Cash Flow
0
0
0
0
-87
-106
Financing Cash Flow
8
5
53
190
6
72
Change in Cash
-10
14
35
150
-139
-20

Global Institutional Holdings in Ars Pharmaceuticals Inc

Funds
Holdings
RA Capital Management, LLC
11.06%
Deerfield Management Co
10.71%
Orbimed Advisors, LLC
8.44%
BlackRock Inc
4.38%
SR ONE CAPITAL MANAGEMENT, LP
4.09%

Insights on Ars Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 7.97M → 15.71M (in $), with an average increase of 49.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 93.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 12.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 49.93M → -44.88M (in $), with an average decrease of 100.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SPRY stock has moved down by -31.5%

About Ars Pharmaceuticals Inc

silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by orbimed.
OrganisationArs Pharmaceuticals Inc
Headquarters11682 El Camino Real, San Diego, CA, United States, 92130
IndustryHealthcare
CEOMr. Richard E. Lowenthal M.B.A., M.S., MSMSEL
E-voting on sharesClick here to vote

Key Management of Ars Pharmaceuticals Inc

Name

Title

Mr. Harris Kaplan M.B.A.

Executive Vice President of Commercial Strategy

Mr. Richard E. Lowenthal M.B.A., M.S., MSMSEL

Co-Founder, President, CEO & Director

Dr. Sarina Tanimoto M.B.A., M.D.

Co-Founder & Chief Medical Officer

Mr. Brian T. Dorsey M.S.

Chief Operating Officer

Dr. Robert Bell Ph.D.

Co-Founder & Chief Science Officer

Mr. Alexander A. Fitzpatrick Esq.

Chief Legal Officer & Secretary

Mr. Daniel Relovsky

Senior Vice President of Marketing

Mr. Justin Chakma

Chief Business Officer

Ms. Kathleen D. Scott CPA

Chief Financial Officer

Mr. Eric Karas

Chief Commercial Officer

FAQs

What is Ars Pharmaceuticals Inc share price today?

Ars Pharmaceuticals Inc share price today is $9.4 as on at the close of the market. Ars Pharmaceuticals Inc share today touched a day high of $10.15 and a low of $9.38.

What is the 52 week high and 52 week low for Ars Pharmaceuticals Inc share?

Ars Pharmaceuticals Inc share touched a 52 week high of $18.9 on and a 52 week low of $9.79 on . Ars Pharmaceuticals Inc stock price today i.e. is closed at $9.4,which is 50.26% down from its 52 week high and -3.98% up from its 52 week low.

What is Ars Pharmaceuticals Inc's market capitalisation today?

Ars Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Ars Pharmaceuticals Inc Stock (SPRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ars Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ars Pharmaceuticals Inc Shares that will get you 0.1596 shares as per Ars Pharmaceuticals Inc share price of $9.4 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Ars Pharmaceuticals Inc Stock (SPRY) from India?

Indian investors can start investing in Ars Pharmaceuticals Inc (SPRY) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Ars Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Ars Pharmaceuticals Inc share’s latest price of $9.4 as on September 17, 2025 at 1:29 am IST, you will get 1.0638 shares of Ars Pharmaceuticals Inc. Learn more about fractional shares .